December 2022 - NetworkNewsWire

ThursdayDec 29, 2022 10:30 am

Want to Fight Climate Change? GeoSolar Technologies Inc. is Helping Homeowners Fight for a Green Revolution

Environmental and regulatory debates create serious challenges in implementing utility-scale renewable energy GeoSolar Technologies has developed a comprehensive home package that allows people to eliminate some utility bills while benefiting from government incentives to install The SmartGreen(TM) Home system can be used in any climate and utilizes solar, geothermal, heat pump and other leading technologies to maximize a home’s efficiency and minimize use of fossil fuels When it comes to climate change, people want answers, not more arguments. In theory, the idea of converting the U.S. to renewable energies sounds easy enough but peeling back layers of the onion reveals…

ThursdayDec 29, 2022 9:45 am

SideChannel Inc. (SDCH) Offering Attractive Cost Advantages as Organizations Brace Themselves for Tighter Economy

SideChannel is a company focused on making cybersecurity simple and accessible based on the belief that all companies, including small and mid-sized businesses, deserve top-tier security guidance Currently, companies are facing the potential of stiffer economic times, demanding more cost-effective solutions to maintain and grow operations In these uncertain times, SideChannel offers a significant cost advantage as it provides top-tier security guidance at a manageable cost In response to tighter budgets, companies have been focused on reducing expenses, streamlining operations, managing cash flows, and building cash reserves, among other interventions. At the same time, companies are recognizing the growing importance…

ThursdayDec 29, 2022 9:00 am

Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) Announces New Financing Round; Looking to Raise up to $1 Million

Reklaim announced financing with gross aggregate proceeds of up to $1 million; the company intends to use the net proceeds to capitalize on a favorable market environment as data privacy gains momentum When California introduced the California Consumer Privacy Act (“CCPA”) in 2018, it set an example for other U.S. states that followed suit, enacting their own privacy laws As new laws enforce additional requirements for brands and businesses regarding their data privacy practices, new opportunities will continue to emerge for companies like Reklaim Reklaim (TSX.V: MYID) (OTCQB: MYIDF), a company focused on enabling consumers to reclaim their online information…

WednesdayDec 28, 2022 12:45 pm

Lift Vancouver 2023 Dedicated to Uplifting the Cannabis Community In Canada

It’s time for cannabis industry leaders and enthusiasts in Canada, and across North America, to gather and refresh their cannabis knowledge and connections at Lift Vancouver 2023 taking place at the Vancouver Convention Centre from January 12-14, 2023. Lift is Canada’s #1 Cannabis Conference and Trade Show, engaged in curating and presenting quality cannabis content to audiences throughout the full cannabis ecosystem while establishing collaborative relationships among them. Lift is a premier networking arena in Canada and beyond for cannabis traders, enthusiasts, industry professionals, consumers, media, and investors, to get direct access to B2B buyers and retailers. The Lift Cannabis…

WednesdayDec 28, 2022 12:00 pm

CubCrafters Inc. Achieves Key Milestones in 2022, Continuing Growth Since Inception

CubCrafters is a producer of best-in-class backcountry aircraft made under the light sport, experimental, and FAA-certified (Part 23 certified) aircraft categories In 2022, the company achieved several milestones, including filing and receiving qualification for a public offering under the Regulation A+ exemption, marking the first time the company has opened to outside investment in its 42-year history The company aims to raise $50 million, channeling the proceeds from the offering toward accelerating manufacturing, enhancing manufacturing capabilities, furthering innovation, and improving customer service CubCrafters also released a new, improved engine for its Experimental aircraft In addition, CubCrafters announced its flagship XCub…

WednesdayDec 28, 2022 11:15 am

Aditxt Inc. (NASDAQ: ADTX) Announces Goal of First-in-Human Trials for Drug Candidate ADI(TM)-100 with a Focus on Psoriasis

Dr. Joachim-Friedrich Kapp is leading Aditxt’s ADI(TM) immune modulation technology development toward clinical trials The global psoriasis therapeutics market was valued at $22.9 billion in 2021 and is projected to reach $55.8 billion by 2031, growing at a CAGR of 9.3% The primary goal of the first-in-human clinical trial is to demonstrate the safety of Aditxt’s ADI(TM) technology; in addition, the trial has been designed to evaluate the ability of ADI(TM) to restore immune tolerance Aditxt (NASDAQ: ADTX), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, is focused on mapping…

WednesdayDec 28, 2022 10:30 am

USDA’s Inclusion of Hemp Data in the 2022 Census for Agriculture is seen as Another Boost to the Cannabis Sector, and REZYFi, Inc. is Set to Benefit from It

The USDA is set to include hemp data in its 2022 Census of Agriculture, another indication of the ongoing growth in support of the overall cannabis industry, benefitting related mortgage origination and financing company REZYFi, Inc. The legal marijuana industry is set to hit 53% in 2026, a 60% growth, with international legal marijuana sales expected to hit $130 billion by 2030 REZYFi is confident that this move by the USDA will yield further growth in the cannabis sector, supporting demand for its product offerings as it expands to additional states throughout the U.S. In 2014, the Farm Bill, regarded…

WednesdayDec 28, 2022 9:45 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Continues to See Growth in Patient Enrollment for Brain Cancer Drug Candidate Global Clinical Trial

CNS Pharmaceuticals is conducting a potentially pivotal clinical trial in the United States and Europe to establish the effectiveness of a drug candidate for combating incurable glioblastoma (“GBM”) brain cancers CNS’s flagship drug candidate is called Berubicin, a product initially developed by another company with encouraging small-population results in 2006, and CNS is expanding the testing with expectations of eventually delivering an innovative new GBM treatment to market The company aims to enroll more than 200 patients in its global Berubicin trial on a 2:1 randomization schema comparing Berubicin-treated patients to those receiving second-line standard of care chemotherapy agent lomustine…

WednesdayDec 28, 2022 9:00 am

M&A Activity Keeps Flora Growth Corp. (NASDAQ: FLGC) Revenues Strong Amid Expected Rebound in Cannabis Industry

Cannabis cultivator and international brand developer Flora Growth has continued to build its revenues through accretive acquisitions during the past year and expects to see revenues continue to rise amid further M&A activity Flora expects to lock in its latest acquisition by the end of the month after shareholders meet to discuss the proposed deal with multi-national operator Franchise Global Health (“FGH”), which would grant Flora immediate access to Germany’s cannabis market and FGH the ability to overcome supply chain difficulties Flora has previously reported cooperative agreements that increase its product distribution pipeline in Europe through Switzerland and the Czech…

TuesdayDec 27, 2022 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Uses Patented DehydraTECH(TM) Technology to Increase Bioavailability in Pharmaceuticals

Studies have indicated that around 40% of the available drugs on the market offer poor bioavailability Lexaria’s patented DehydraTECH(TM) technology increases bioavailability, improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery The global pharmaceutical drug delivery market was valued at $1.66 billion in 2021 and is expected to grow at a CAGR of 5.9%, resulting in a value of $2.21 billion by 2026 One of the main concerns associated with marketed drugs is low bioavailability. Bioavailability is the amount of a drug or substance that becomes completely available to the intended biological destination…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

Month: December 2022